
Stephen V Liu, MD
@stephenvliu
Director of Thoracic Oncology & Developmental Therapeutics @Georgetown @LombardiCancer; Co-Host @IASLC Podcast; Chair #TexasLung25 #DCLung25; #HereWeGo
ID: 377425889
https://www.medstarhealth.org/doctors/stephen-liu-md 21-09-2011 15:17:53
19,19K Tweet
26,26K Takipçi
3,3K Takip Edilen

Characterization of adenosquamous NSCLC and carcinosarcoma from The Shields Lab now JTO & JTO CRR. Actionable alterations (including METex14, EGFR, KRAS G12C, ALK, RET) seen in 37% of adenosquamous and in 17% of carcinosarcoma samples. jto.org/article/S1556-…